$NEOG SEC Filings

Filed On	Filing
28 Oct 2026	144
26 Oct 2026	8-K/A: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers At the annual meeting of shareholders of Neogen Corporation (the “Company”) held on October 1, 2026, the Company’s shareholders approved the Neogen Corporation Amended and Restated Omnibus Incentive Plan (the “Plan”). The Plan is an amen...
23 Oct 2026	Form 4: Hastings Gregory S, VP, Animal Health Received 287 shares by exercise or conversion ($3.44K) · Gave up 80 shares to cover exercise price or tax ($960)
23 Oct 2026	Form 3: Hastings Gregory S, VP, Animal Health Holds 32,368 shares of Common Stock
21 Oct 2026	Form 3: Walter James A, SVP of Manufacturing Holds 28,955 shares of Common Stock
21 Oct 2026	Form 3: Yarwood Jeremy, Chief Scientific Officer Holds 297 shares of Common Stock
21 Oct 2026	Form 3: Freels Joe B, Chief Commercial Officer No securities owned
20 Oct 2026	S-8
20 Oct 2026	S-8
09 Oct 2026	Form 4: Nassif Mikheal, Director Bought 505 shares ($6.03K)
07 Oct 2026	10-Q
07 Oct 2026	8-K: Submission of Matters to a Vote of Security Holders On October 1, 2026, the Company held its 2026 Annual Meeting of Shareholders. At the meeting, 176,180,487 of the 218,106,005 shares outstanding and entitled to vote were present and voted. The matters listed below were submitted to a vot...
06 Oct 2026	8-K: Results of Operations and Financial Condition Revenue of $222.8 million, representing growth of 6.5% and Core Growth1 of 8.1%
02 Oct 2026	Form 4: Woteki Catherine E, Director Received 9,804 shares as a grant or award ($120K) · Granted 20,558 Common Stock (Right to Buy)
02 Oct 2026	Form 4: Wainer Andrea F, Director Received 9,804 shares as a grant or award ($120K) · Granted 20,558 Common Stock (Right to Buy)
02 Oct 2026	Form 4: Rodriguez Rafael A, Director Received 9,804 shares as a grant or award ($120K) · Granted 20,558 Common Stock (Right to Buy)
02 Oct 2026	Form 4: Pelossof Avi, Director Received 9,804 shares as a grant or award ($120K) · Granted 20,558 Common Stock (Right to Buy)
02 Oct 2026	Form 4: Gupta Aashima, Director Received 9,804 shares as a grant or award ($120K) · Granted 20,558 Common Stock (Right to Buy)
02 Oct 2026	Form 4: Green Ronald D, Director Received 9,804 shares as a grant or award ($120K) · Granted 20,558 Common Stock (Right to Buy)
02 Oct 2026	Form 4: Capello Jeffrey D, Director Received 9,804 shares as a grant or award ($120K) · Granted 20,558 Common Stock (Right to Buy)

Comments